During the past decade, Eye Surgery Associates conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Eye Surgery Associates" are "Geographic Atrophy" (2 trials), "Age Related Macular Degeneration" (1 trials) and "Macular Degeneration" (1 trials). Many other conditions were trialed in "Eye Surgery Associates" in a lesser frequency.

Most popular intervention types in "Eye Surgery Associates" are "Drug" (2 trials). Other intervention types were less common.

The name of intervention was led by "IONIS-FB-LRx" (1 trials), "IONIS-FB-Lrx" (1 trials), "Placebo" (1 trials) and "Placebo (sterline saline 0.9%)" (1 trials). Other intervention names were less common.

The vast majority of trials in "Eye Surgery Associates" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Eye Surgery Associates". undefined are not yet recruiting, undefined are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in Eye Surgery Associates, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Eye Surgery Associates, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".